‘Acridines’ as New Horizons in Antifungal Treatment - Publication - MOST Wiedzy

Search

‘Acridines’ as New Horizons in Antifungal Treatment

Abstract

Frequent fungal infections in immunocompromised patients and mortality due to invasive mycosis are important clinical problems. Opportunistic pathogenic Candida species remain one of the leading causes of systemic mycosis worldwide. The repertoire of antifungal chemotherapeutic agents is very limited. Although new antifungal drugs such as lanosterol 14α-demethylase and β-glucan synthase inhibitors have been introduced into clinical practice, the development of multidrug resistance has become increasingly significant. The urgency to expand the range of therapeutic options for the treatment of fungal infections has led researchers in recent decades to seek alternative antifungal targets to the conventional ones currently used. Among them, many compounds containing an acridine scaffold have been synthesized and tested. In this review, the applicability of acridines and their functional analogues acridones as antifungal agents is described. Acridine derivatives usage in photoantifungal chemotherapy, interactions with fungal transporters resulting in modulation of efflux/influx pumps and the effect of acridine derivatives on fungal topoisomerases are discussed. This article explores new perspectives on the mechanisms of antifungal acridine-peptide conjugates and acridine-based hybrid molecules to effectively combat fungal infections.

Citations

  • 2

    CrossRef

  • 2

    Web of Science

  • 2

    Scopus

Details

Category:
Articles
Type:
artykuły w czasopismach
Published in:
MOLECULES no. 25,
ISSN: 1420-3049
Language:
English
Publication year:
2020
Bibliographic description:
Gabriel I.: ‘Acridines’ as New Horizons in Antifungal Treatment// MOLECULES -Vol. 25,iss. 7 (2020), s.1480-
DOI:
Digital Object Identifier (open in new tab) 10.3390/molecules25071480
Verified by:
Gdańsk University of Technology

seen 22 times

Recommended for you

Meta Tags